yielding a yellow solution. Stirring was stopped after 15 min,
and the volatiles were evaporated under vacuum. The pale yellow
solid was suspended in hexanes (20 mL), filtered through a frit,
and vacuum dried overnight to give 0.1380 g product (94%).
1H NMR (CDCl3): d 1.40 (s, 3H, OC(O)C(CH3)(CH¢3)O),
1.40 (s, 3H, OC(O)C(CH3)(CH¢3)O), 2.08 (s, 3H, NCH3), 2.24
(dd, 13, 2.5 Hz, 1H, NCH2CHHN), 2.45 (dd, 13, 2.5 Hz, 1H,
NCHHCH2N), 2.83 (s, 3H, NCH3), 3.02 (td, 13, 2.5 Hz, 1H,
NCH2CHHN), 3.18 (d, 13.5 Hz, 1H, NCHH¢Ar), 3.48 (d, 14 Hz,
1H, NCHH¢Ar), 3.59 (td, 13, 2.5 Hz, 1H, NCHHCH2N), 4.66
(d, 14 Hz, 1H, NCHH¢Ar), 5.00 (d, 13.5 Hz, 1H, NCHH¢Ar),
6.61 (d, 8.5 Hz, 1H, Ar 3-H), 6.65 (d, 8.5 Hz, 1H, Ar 3-H),
7.13 (d, 2 Hz, 1H, Ar 6-H), 7.28 (d, 2 Hz, 1H, Ar 6-H), 7.30
(dd, 9, 3 Hz, 1H, Ar 4-H), 7.34 (dd, 9, 2.5 Hz, 1H, Ar 4-H).
12 Hz, 1H, NCHH¢CH2N), 2.75 (s, 3H, NCH3), 3.11 (d, 14 Hz,
1H, NCHH¢Ar), 3.10 (t, 11 Hz, 1H, NCH2CHH¢N), 3.34 (d,
14 Hz, 1H, NCHH¢Ar), 3.52 (t, 11 Hz, 1H, NCHH¢CH2N), 3.79
(s, 12H, OCH3), 4.63 (d, 14 Hz, 1H, NCHH¢Ar), 4.92 (d, 14 Hz,
1H, NCHH¢Ar), 6.58 (d, 9 Hz, 1H, Ar 3-H), 6.61 (d, 9 Hz, 1H, Ar
3-H), 6.67 (d, 2 Hz, 1H, Ar 6-H), 6.77-6.84 (m, 3H, ArH), 6.79 (d,
9 Hz, 4H, NC6H4OCH3 2,6-H), 6.80 (d, 9 Hz, 4H, NC6H4OCH3
2,6-H), 6.98 (d, 9 Hz, 4H, NC6H4OCH3 3,5-H), 6.99 (d, 9 Hz,
1
4H, NC6H4OCH3 3,5-H). 13C{ H} NMR (CDCl3): d 26.74
(OC(O)C(CH3)(CH¢3)O), 27.92 (OC(O)C(CH3)(CH¢3)O), 43.21
(NCH3), 50.48 (NCH3), 51.99 (NCH2CH2N), 55.71 (OCH3),
57.40 (NCH2CH2N), 64.15 (NCH2Ar), 64.58 (NCH2Ar), 92.78
(OC(O)C(CH3)2O), 114.73, 114.84, 116.55, 117.01, 123.52,
123.59, 123.85, 124.58, 125.31, 125.42, 125.74, 125.98, 141.64,
141.88, 142.05, 142.70, 155.22, 155.59, 156.29, 187.07 (C O).
IR: 1676 (s, nC O), 1604 (w), 1504 (sh), 1489 (sh), 1300 (w), 1262
(w), 1239 (s), 1197 (w), 1120 (w), 1034 (m), 979 (w), 887 (s), 823
(s), 781 (m), 729 (s), 664 (w). UV-vis: 405 (2.6 ¥ 104), 297 (7.1 ¥
104). FABMS: 903 (M+). Anal. Calcd for C50H54N4O9Ti: C, 66.52;
H, 6.03; N, 6.21. Found: C, 66.46; H, 6.01; N, 5.98.
1
13C{ H} NMR (CDCl3): d 26.48 (OC(O)C(CH3)(CH¢3)O), 27.63
(OC(O)C(CH3)(CH¢3)O), 42.85 (NCH3), 50.84 (NCH3), 52.12
(NCH2CH2N), 57.23 (NCH2CH2N), 63.46 (NCH2Ar), 63.85
(NCH2Ar), 94.31 (OC(O)C(CH3)2O), 112.41, 113.20, 118.00,
118.40, 125.84, 127.10, 131.75, 132.24, 132.61, 133.31, 159.35,
159.83, 186.66 (C(O)O). IR: 1685 (m, nC O), 1410 (w), 1268 (s),
1192 (m), 1121 (w), 973 (w), 820 (m), 723 (m), 675 (m). UV-vis:
334 (2.4 ¥ 104), 301 (1.9 ¥ 104). FAB-MS: 605 (M+H+). Anal.
Calcd for C22H26Br2N2O5Ti: C, 43.59; H, 4.32; N, 4.62. Found: C,
43.33; H, 4.29; N, 4.43.
[N,N¢-Dimethyl-N,N¢-bis-(2-oxido-5-(di-(4-methoxyphenyl)-
amino)benzyl)ethylenediamine](2,2-dimethyl-3-oxidopropanoato)-
titanium(IV), An2NLTi(OCH2C(CH3)2C(O)O). The compound
was prepared from An2NLTi(OiPr)2 (0.1500 g, 0.163 mmol) and
hydroxypivalic acid (0.0193 g, 0.163 mmol) using the same
procedure employed for the a-hydroxybutyrate compound to
[N,N¢-Dimethyl-N,N¢-bis-(2-oxido-5-bromobenzyl)ethylenedi-
amine](2,2-dimethyl-3-oxidopropanoato)titanium(IV),
BrLTi(O-
CH2C(CH3)2C(O)O). BrLTi(OiPr)2 (0.1500 g, 0.241 mmol) and
hydroxypivalic acid (Aldrich, 0.0285 g, 0.241 mmol) were reacted
as described for the a-hydroxyisobutyrate derivative to yield
0.1330 g (89%) of the hydroxypivalate complex. 1H NMR (CDCl3):
d 1.14 (s, 3H, C(CH3)(CH¢3)), 1.40 (s, 3H, C(CH3)(CH¢3)), 2.13 (s,
3H, NCH3), 2.21 (dd, 14, 2 Hz, 1H, NCHH¢CH2N), 2.38 (dd, 13,
2 Hz, 1H, NCH2CHH¢N), 2.77 (s, 3H, NCH3), 3.03 (td, 13, 2 Hz,
1H, NCHH¢CH2N), 3.11 (d, 14 Hz, 1H, NCHH¢Ar), 3.40 (d,
14 Hz, 1H, NCHH¢Ar), 3.69 (td, 13, 3 Hz, 1H, NCH2CHH¢N),
3.89 (d, 12 Hz, 1H, NCHH¢Ar), 4.51 (d, 12 Hz, 1H, NCHH¢Ar),
4.58 (d, 13 Hz, 1H, OC(O)C(CH3)2CHH¢O), 4.99 (d, 14 Hz, 1H,
OC(O)C(CH3)2CHH¢O), 6.57 (d, 8.5 Hz, 1H, Ar 3-H), 6.65 (d,
8.5 Hz, 1H, Ar 3-H), 7.13 (d, 2 Hz, 1H, Ar 6-H), 7.24 (d, 2 Hz, 1H,
Ar 6-H), 7.29 (dd, 7, 2 Hz, 1H, Ar 4-H), 7.32 (dd, 9, 2.5 Hz, 1H,
yield 0.1264 g (84%) of the hydroxypivalate complex. H NMR
1
(CDCl3): d 1.13 (s, 3H, OCH2C(CH3)(CH¢3)C(O)O), 1.44 (s, 3H,
OCH2C(CH3)(CH¢3)C(O)O), 2.11 (d, 12 Hz, 1H, NCH2CHH¢N),
2.21 (s, 3H, NCH3), 2.70 (d, 12 Hz, 1 H, NCHHCH2N), 2.69
(s, 3H, NCH3), 3.01 (d, 13.5 Hz, 1H, NCHH¢Ar), 3.11 (t,
13 Hz, 1H, NCH2CHH¢N), 3.28 (d, 14 Hz, 1H, NCHH¢Ar),
3.63 (t, 13 Hz, 1H, NCHH¢CH2N), 3.79 (s, 12H, OCH3), 3.89
(d, 12 Hz, 1H, NCHH¢Ar), 4.45 (d, 12 Hz, 1H, NCHH¢Ar),
4.53 (d, 13 Hz, 1H, OCHH¢C(CH3)2C(O)O), 4.92 (d, 13 Hz, 1H,
OCHH¢C(CH3)2C(O)O), 6.55 (d, 8.5 Hz, 1H, Ar 3-H), 6.60 (d,
8.5 Hz, 1H, Ar 3-H), 6.66 (d, 2.5 Hz, 1H, Ar 6-H), 6.74 (d, 3 Hz,
Ar 6-H), 6.79-6.85 (m, 10H, NC6H4OCH3 2,6-H and Ar 4-H), 6.97
(d, 9 Hz, 4H, NC6H4OCH3 3,5-H), 6.99 (d, 9 Hz, 4H, NC6H4OCH3
1
3,5-H). 13C{ H} NMR (CDCl3): d 22.86 (OC(O)C(CH3)(CH¢3)O),
1
Ar 4-H). 13C{ H} NMR (CDCl3): d 22.63 (C(CH3)(CH¢3)), 24.08
24.26 (OC(O)C(CH3)(CH¢3)O), 43.47 (OCH2C(CH3)2C(O)O),
43.56 (NCH3), 50.19 (NCH3), 52.65 (NCH2CH2N), 55.72 (OCH3),
56.92 (NCH2CH2N), 64.11 (NCH2Ar), 64.71 (NCH2Ar), 83.23
(OCH2C(CH3)2C(O)O), 114.73, 114.81, 116.63, 117.22, 123.47,
123.71, 123.92, 124.03, 125.12, 125.39, 125.54, 125.65, 141.77,
141.86, 142.02, 142.05, 155.23, 155.44, 155.60, 156.18, 181.14
(C O). IR: 1652 (m, nC O), 1502 (w), 1295 (w), 1261 (sh), 1236
(s), 1171 (m), 1034 (m), 888 (w), 813 (w). UV-vis (toluene): 419
(2.0 ¥ 104), 299 (5.9 ¥ 104). FAB-MS: 917 (M+H+). Anal. Calcd
for C51H56N4O9Ti: C, 66.81; H, 6.16; N, 6.11. Found: C, 65.93; H,
5.97; N, 5.80.
(C(CH3)(CH¢3)), 43.31 (OC(O)C(CH3)2CH2O), 43.36 (NCH3),
50.50 (NCH3), 52.74 (NCH2CH2N), 56.79 (NCH2CH2N), 63.52
(NCH2Ar), 64.07 (NCH2Ar), 83.98 (OC(O)C(CH3)2CH2O),
112.34, 112.38, 118.21, 118.63, 126.38, 126.80, 131.80, 132.05,
132.48, 133.18, 159.54, 159.67, 180.65 (TiOC(O)). IR: 1653 (s,
nC O), 1408 (m), 1261 (m), 1170 (m), 1119 (w), 1064 (m), 894 (w),
814 (m), 721 (w), 676 (s). UV-vis: 332 (2.3 ¥ 104), 303 (1.7 ¥ 104).
FAB-MS: 619 (M+H+). Anal. Calcd for C23H28Br2N2O5Ti: C,
44.54; H, 4.55; N, 4.52. Found: C, 44.65; H, 4.33; N, 3.48.
[N,N¢-Dimethyl-N,N¢-bis-(2-oxido-5-(di-(4-methoxyphenyl)-
amino)benzyl)ethylenediamine](2-methyl-2-oxidopropanoato)titan-
ium(IV), An2NLTi(OC(CH3)2C(O)O). The compound was
prepared as described for the bromosalan analogue using
An2NLTi(OiPr)2 (0.1500 g, 0.163 mmol) to give 0.1180 g (79%)
of the chelated product. 1H NMR (CDCl3): d 1.40 (s, 3H,
OC(O)C(CH3)(CH¢3)O), 1.63 (s, 3H, OC(O)C(CH3)(CH¢3)O),
2.14 (d, 12 Hz, 1H, NCH2CHH¢N), 2.20 (s, 3H, NCH3), 2.40 (d,
[N,N¢-Dimethyl-N,N¢-bis-(2-oxido-5-(di-(4-methoxyphenyl)-
amino)benzyl)ethylenediamine]-titanium(IV) dichloride, An2NLTiCl2.
An2NLTi(OiPr)2 (0.1600 g, 0.174 mmol) was weighed into a
50 mL round-bottom flask with a stir bar and dissolved in
CH2Cl2 (15 mL). To this solution, trimethylsilyl chloride (Aldrich,
0.0464 g, 0.427 mmol) in CH2Cl2 (5 mL) was added dropwise
with vigorous stirring. The round-bottom flask was capped with
This journal is
The Royal Society of Chemistry 2011
Dalton Trans., 2011, 40, 11458–11468 | 11461
©